Search for other papers by Xiuzhen Zhang in
Google Scholar
PubMed
Search for other papers by Dan Xu in
Google Scholar
PubMed
Search for other papers by Ping Xu in
Google Scholar
PubMed
Search for other papers by Shufen Yang in
Google Scholar
PubMed
Search for other papers by Qingmei Zhang in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Fengyi Yuan in
Google Scholar
PubMed
Introduction Amongst the background of the rising incidence of type 1 diabetes mellitus (T1DM) across the globe, public concern has reached a new high ( 1 ). Despite progress in diabetes care, as the leading cause of mortality in T1DM ( 2
Search for other papers by Jun-Xin Yan in
Google Scholar
PubMed
Search for other papers by Bin-Jing Pan in
Google Scholar
PubMed
Search for other papers by Ping-Ping Zhao in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Li-Ting Wang in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Jing-Fang Liu in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Song-Bo Fu in
Google Scholar
PubMed
the difference in serum ferritin levels between the two groups was compared. The patients with T2DM with NAFLD were grouped according to the quintile levels of serum ferritin: F 1 (0–76.5 ng/mL), F 2 (76.5–117.88 ng/mL), F 3 (117.88–181.31 ng
Search for other papers by Yuan Fang in
Google Scholar
PubMed
Search for other papers by Xuehong Zhang in
Google Scholar
PubMed
Search for other papers by Huilin Xu in
Google Scholar
PubMed
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Search for other papers by Stephanie A Smith-Warner in
Google Scholar
PubMed
Search for other papers by Dongli Xu in
Google Scholar
PubMed
Search for other papers by Hong Fang in
Google Scholar
PubMed
Search for other papers by Wang Hong Xu in
Google Scholar
PubMed
Introduction Type 2 diabetes (T2DM) has been associated with an elevated risk of liver, pancreas, endometrium, colorectal, breast and bladder cancers and a decreased risk of prostate cancer ( 1 , 2 ). Several possible mechanisms have been
Search for other papers by W Liu in
Google Scholar
PubMed
Search for other papers by Y Wang in
Google Scholar
PubMed
Search for other papers by X Han in
Google Scholar
PubMed
Search for other papers by X Cai in
Google Scholar
PubMed
Search for other papers by Y Zhu in
Google Scholar
PubMed
Search for other papers by M Zhang in
Google Scholar
PubMed
Search for other papers by S Gong in
Google Scholar
PubMed
Search for other papers by J Li in
Google Scholar
PubMed
Search for other papers by L Ji in
Google Scholar
PubMed
Introduction Chronic complications cause the largest proportion of deaths and increase in prevalence with the duration of the disease in long-standing type 1 diabetes (T1DM). ( 1 ) Indeed, the duration of diabetes and severity of hyperglycemia
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Punith Kempegowda in
Google Scholar
PubMed
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Eka Melson in
Google Scholar
PubMed
Search for other papers by Agnes Johnson in
Google Scholar
PubMed
Search for other papers by Lucy Wallett in
Google Scholar
PubMed
Search for other papers by Lucretia Thomas in
Google Scholar
PubMed
Search for other papers by Dengyi Zhou in
Google Scholar
PubMed
Search for other papers by Catherine Holmes in
Google Scholar
PubMed
Search for other papers by Agata Juszczak in
Google Scholar
PubMed
Search for other papers by Mohammed Ali Karamat in
Google Scholar
PubMed
Search for other papers by Sandip Ghosh in
Google Scholar
PubMed
Search for other papers by Wasim Hanif in
Google Scholar
PubMed
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Search for other papers by Parth Narendran in
Google Scholar
PubMed
School of Life and Health Sciences, Aston University, Birmingham, UK
Search for other papers by Srikanth Bellary in
Google Scholar
PubMed
times greater mortality from COVID-19 for those with type 2 diabetes (T2DM) and 3.5 times in those with type 1 diabetes mellitus (T1DM) compared to those without diabetes ( 2 ). Importantly, the majority of these deaths occurred in the elderly, and the
Postgraduation Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Taís S Assmann in
Google Scholar
PubMed
Search for other papers by Mariana Recamonde-Mendoza in
Google Scholar
PubMed
Postgraduation Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Bianca M De Souza in
Google Scholar
PubMed
Postgraduation Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Daisy Crispim in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of pancreatic beta-cells by T lymphocytes and macrophages ( 1 ). The disease is usually diagnosed when over 80–90% of beta-cells have been destructed by
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
Search for other papers by Christina Bothou in
Google Scholar
PubMed
Search for other papers by Justyna Kuliczkowska-Płaksej in
Google Scholar
PubMed
Search for other papers by Ralitsa Robeva in
Google Scholar
PubMed
Search for other papers by Andromahi Vryonidou in
Google Scholar
PubMed
Search for other papers by Jelica Bjekic Macut in
Google Scholar
PubMed
Search for other papers by Ioannis Androulakis in
Google Scholar
PubMed
Search for other papers by Milica Opalic in
Google Scholar
PubMed
Search for other papers by Zadalla Mouslech in
Google Scholar
PubMed
Search for other papers by Andrej Milewicz in
Google Scholar
PubMed
Search for other papers by Alessandra Gambineri in
Google Scholar
PubMed
Search for other papers by Dimitrios Panidis in
Google Scholar
PubMed
Search for other papers by Djuro Macut in
Google Scholar
PubMed
, accompanied by oligomenorrhea, dominate the clinical picture followed by metabolic disorders including dysglycemia and dyslipidemia later in life ( 1 ). Moreover, progression of normoglycemia to either intermediate hyperglycemia or diabetes mellitus (T2DM) has
Search for other papers by Zhenyu Liu in
Google Scholar
PubMed
Search for other papers by Huixi Kong in
Google Scholar
PubMed
Search for other papers by Baoyu Zhang in
Google Scholar
PubMed
Introduction According to recent statistics, 529 million people will have diabetes worldwide in 2021, and the global age-standardized total diabetes prevalence will be 6.1% ( 1 ). Type 2 diabetes mellitus (T2DM) is the most frequent form of
Search for other papers by Rui Zhang in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Yue Li in
Google Scholar
PubMed
Search for other papers by Zhiyan Yu in
Google Scholar
PubMed
Search for other papers by Yueyue Wu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
Search for other papers by Heyuan Ding in
Google Scholar
PubMed
Search for other papers by Shufei Zang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Introduction There is a close association between type 2 diabetes mellitus (T2DM) and iron overload ( 1 , 2 , 3 ). The association between diabetes and iron metabolism in humans was first demonstrated by clinical observations of individuals
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Nektaria Papadopoulou-Marketou in
Google Scholar
PubMed
Search for other papers by George P Chrousos in
Google Scholar
PubMed
Search for other papers by Christina Kanaka-Gantenbein in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM) represents only around 10% of the diabetes cases worldwide, but occurs with increasing incidence much earlier in life. T1DM results from the autoimmune destruction of β cells of the endocrine